Industry Overview
The Problem
- Though the ability of preventing Ischemic Stroke is real, current modalities and procedures do not allow for intervention prior to the occurrence
- A patient is only sent for arterial evaluation if they are presenting symptoms of stroke, and since stroke is frequently asymptomatic there typically is no further testing
- There is a high cost associated with current screening modalities available (Duplex Doppler Ultrasound, MRA, CTA, and Digital Subtraction) which compound this problem
![](http://cvrmed.com/wp-content/uploads/2020/06/doctors.jpg)
Stroke/Carotid Artery Disease Statistics
![](http://cvrmed.com/wp-content/uploads/2020/07/icon_crutch.png)
Leading Cause of Disability (Globally)
![](http://cvrmed.com/wp-content/uploads/2020/07/icon_pulse.png)
3rd Leading Cause of Death (USA)
![](http://cvrmed.com/wp-content/uploads/2020/07/icon_heart.png)
Asymptomatic
![](http://cvrmed.com/wp-content/uploads/2020/07/icon_brain.png)
795,000 Stroke Incidents Yearly (USA)
Ischemic
87%
Hemorrhagic
13%
![](http://cvrmed.com/wp-content/uploads/2020/07/icon_clipboard.png)
3rd Leading Cause of Death (USA)
Permanent Impairment
50%
Recover
38%
Fatal
12%
![](http://cvrmed.com/wp-content/uploads/2020/07/icon_money.png)
Cost
2010
$71.6 Billion
2030
Cost Estimated to Triple
![Picture1](http://cvrmed.com/wp-content/uploads/2020/07/Picture1.gif)
![Picture2](http://cvrmed.com/wp-content/uploads/2020/07/Picture2.png)
Previous
Next
![](http://cvrmed.com/wp-content/uploads/2020/07/Current-Modalities-1024x518.png)